Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced in brain excitatory neurons (635 nCPM) | 1.00 |
| chemistry Open Targets | reachable by antibody | 0.36 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 15462
Sealed predictions
- LRFN5 in dopamine neurons, braak+0.67 (p 0.048) → +0.37 (p 0.329)receipt 15469
Swarm cases
receipt 15469: LRFN5 in dopamine neurons, braak
- power
- full sample +0.50 (p 0.034, n 18), 95% CI +0.04 to +0.78. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.49 (p 0.039, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.43 (p 0.072, n 18). could be the mix.
- skeptic
- leave-one-out range +0.44 to +0.69, sign flips 0; without severely affected donors +0.50 (p 0.034, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LRFN5 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts